Le Lézard
Classified in: Health, Covid-19 virus
Subjects: LEG, LBR, AVO

Media Statement - ONA Joins the Call for Paid Sick Leave for all Ontario Workers


TORONTO, Feb. 16, 2021 /CNW/ - The Ontario Nurses' Association (ONA) ? which represents 68,000 registered nurses and health-care professionals, as well as more than 18,000 nursing students ? joins the call for paid sick leave for all workers.

The province has seen the devastating impact of COVID-19 and the very real impact of workers who do not have access to paid sick leave. Many Ontarians are tragically in the position of having to choose to go to work while ill or lose the income they desperately need to pay rent and feed their families. It is untenable and in 2021, it is simply wrong.

ONA points to the latest modelling projections provided last week by public health officials; Ontario will not be able to control the virus without having the safety net of paid sick days.

With the NDP's proposed Bill 239, the Stay Home If You Are Sick Act, workers can take the time they need to get well while also helping to prevent the spread of COVID-19. The Bill would guarantee 10 personal emergency leave days per year for every worker, seven of which are paid. This would go a long way in Ontario's prevention efforts.

ONA endorses Bill 239 and encourages all MPPs to consent to this Bill.

ONA is the union representing more than 68,000 registered nurses and health-care professionals, as well as 18,000 nursing student affiliates, providing care in hospitals, long-term care facilities, public health, the community, clinics and industry.

www.ona.orgFacebook.com/OntarioNursesTwitter.com/OntarioNurses instagram.com/ontario.nurses

SOURCE Ontario Nurses' Association


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: